NCT00137410View on ClinicalTrials.gov

Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Osteoarthritis,Knee
Interventions
DRUG

Celebrex

Trial Locations (16)

16011

Pfizer Investigational Site, Arenzano (GE)

16100

Pfizer Investigational Site, Genova

16132

Pfizer Investigational Site, Genova

20122

Pfizer Investigational Site, Milan

20157

Pfizer Investigational Site, Milan

27100

Pfizer Investigational Site, Pavia

30122

Pfizer Investigational Site, Venezia

35100

Pfizer Investigational Site, Padua

53100

Pfizer Investigational Site, Siena

60035

Pfizer Investigational Site, Jesi ( AN)

70018

Pfizer Investigational Site, Rutigliano

71100

Pfizer Investigational Site, Foggia

85100

Pfizer Investigational Site, Potenza

90146

Pfizer Investigational Site, Palermo

Unknown

Pfizer Investigational Site, Cagliari - Monserrato

00149

Pfizer Investigational Site, Roma

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00137410 - Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee | Biotech Hunter | Biotech Hunter